Search Orphan Drug Designations and Approvals
-
Generic Name: | Recombinant anti-claudin 18.2 monoclonal antibody |
---|---|
Date Designated: | 08/03/2021 |
Orphan Designation: | Treatment of Gastric Cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Hengenix Biotech, Inc. 430 N. McCarthy Blvd. Milpitas, California 95035 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-